Cited by 480Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and ManagementDiabetes Management and Research

Pre-Diabetes and the Risk for Cardiovascular Disease

Open access
Ford, Earl S., Zhao, Guixiang, Li, Chaoyang·2010·Journal of the American College of Cardiology

Abstract

Objectives Our objective was to estimate the magnitude of the relative risk (RR) for cardiovascular disease associated with impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) from published prospective observational studies.Background Hyperglycemia is a known risk factor for cardiovascular disease. However, the magnitude of the RR for cardiovascular disease associated with IFG and IGT is unclear.Methods We searched PubMed from 1997 through 2008 for relevant publications and performed a meta-analysis.Results In 18 publications with information about IFG (110 to 125 mg/dl) (IFG 110), estimates of RR ranged from 0.65 to 2.50. The fixed-effects summary estimate of RR was 1.20 (95% confidence interval [CI]: 1.12 to 1.28). In 8 publications with information about IFG (100 to 125 mg/dl) (IFG 100), estimates of RR ranged from 0.87 to 1.40. The fixed-effects summary estimate of RR was 1.18 (95% CI: 1.09 to 1.28). In 8 publications with information about IGT, estimates of RR ranged from 0.83 to 1.34. The fixed-effects summary estimate of RR was 1.20 (95% CI: 1.07 to 1.34). Five studies combined IFG and IGT, yielding a fixed-effects summary estimate of RR of 1.10 (95% CI: 0.99 to 1.23). No significant difference between the summary estimates for men and women were detected (IFG 110: men: 1.17 [95% CI: 1.05 to 1.31], women: 1.30 [95% CI: 1.10 to 1.54]; IFG 100: men: 1.23 [95% CI: 1.06 to 1.42], women: 1.16 [95% CI: 0.99 to 1.36]).Conclusions Impaired fasting glucose and IGT are associated with modest increases in the risk for cardiovascular disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2009.10.060

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Cardiovascular mortality is significantly increased in prediabetic patients compared to patients with normal blood glucose.

    “Cardiovascular mortality is also significantly increased in prediabetic patients compared to patients with normal blood glucose.[14, 15]”

    From Postprandial Reactive Hypoglycemia (2019) · cites this paper as [14]

    The Results (page unavailable) report significantly elevated pooled risks for cardiovascular disease outcomes with impaired fasting glucose and impaired glucose tolerance. But the review pools cardiovascular disease outcomes rather than establishing a separate, statistically significant increase in cardiovascular mortality; its combined IFG/IGT estimate also has a confidence interval spanning 1. The claim is therefore more specific and categorical than the reported findings. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • Ford et al estimated a relative risk of cardiovascular disease of 1.18 (95% CI 1.09-1.28) when 5.5 mmol/L (IFG-ADA) was used.

    “a relative risk of 1.18 (95% CI 1.09-1.28) when 5.5 mmol/L (IFG-ADA) was used.”

    From The Vasculature in Prediabetes (2018) · cites this paper as [24]

  • Ford et al estimated a relative risk of cardiovascular disease of 1.20 (95% CI 1.12-1.28) when 6.1 mmol/L was used to define IFG (IFG-WHO).

    “Ford et al estimated a relative risk of cardiovascular disease of 1.20 (95% CI 1.12-1.28) when 6.1 mmol/L (110 mg/dL) was used to define IFG (IFG-WHO)”

    From The Vasculature in Prediabetes (2018) · cites this paper as [24]

  • The relative risk of cardiovascular disease associated with IGT was similar to that for IFG.

    “The relative risk associated with IGT was similar.”

    From The Vasculature in Prediabetes (2018) · cites this paper as [24]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Tobias A. Assessing the influence of a single study in meta-analysis. Stata Tech Bull 1999;47:15-7.
  2. The DECODE Study Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001;161:397-405.

Cited by

Sorted by citations

Authors
Ford, E. S., Zhao, G., & Li, C.
Affiliations
Centers for Disease Control and Prevention (US)
Corresponding author
Ford, Earl S.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2010-03
Volume
55
Issue
13
Pages
1310-1317
ISSN
0735-1097 (ISSN-L)
OpenAlex
W35781219
Cited by
480
References
54
Citations by year
2026: 8 · 2025: 21 · 2024: 17 · 2023: 21 · 2022: 28 · 2021: 30 · 2020: 25 · 2019: 27 · 2018: 47 · 2017: 33 · 2016: 45 · 2015: 29 · 2014: 36 · 2013: 37 · 2012: 48
FWCI
26.78
Type
journal article
Language
en
Open access
Locations
  • Journal of the American College of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
prediabetes, cardiovascular risk, impaired fasting glucose, impaired glucose tolerance, hyperglycemia, relative risk, sex differences
MeSH terms
Cardiovascular Diseases, Diabetic Angiopathies, Humans, Hyperglycemia, Prediabetic State, Risk Factors, Glucose Intolerance, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review